Presentation is loading. Please wait.

Presentation is loading. Please wait.

Driving Innovation Biomedical Catalyst Get involved Follow us on or join the conversation using #BMC Find innovators on _connect https://

Similar presentations


Presentation on theme: "Driving Innovation Biomedical Catalyst Get involved Follow us on or join the conversation using #BMC Find innovators on _connect https://"— Presentation transcript:

1 Driving Innovation Biomedical Catalyst Get involved Follow us on twitter @innovate_uk or join the conversation using #BMC Find innovators on _connect https:// https://connect.innovateuk.orghttps://connect.innovateuk.org Visit www.innovateuk.orgwww.innovateuk.org Dr Helen Kuhlman Lead Technologist, Medicines & Healthcare

2 competitions@innovateuk.org Competition Helpline: 0300 321 4357 www.innovateuk.org _connect Network: https://ktn.innovateuk.orghttps://ktn.innovateuk.org For more information...

3 Joint Technology Strategy Board and Medical Research Council programme investing £180m over 3 years Deliver growth to the UK life sciences sector through supporting and driving the development of innovative life sciences products and services Supporting both academically- and commercially-led research and development and encouraging partnership between clinicians, academics and industry Moving innovative life sciences products and services quicker and more effectively to commercialisation – and ultimately healthcare impact

4 Create a more competitive Life Sciences sector in the UK; Accelerate new products and services onto the market which will have a positive impact on the health of our society; Lever in significant private investment; Create new employment opportunities; Create better synergies and sustained collaborative relationships between the business community and the clinical and academic communities; Increase the amount of R&D investment in the UK; What do we want to achieve?

5 Feasibility Award/CIC Early Stage Award (DPFS) Late Stage Award (DCS) Feasibility Award/CIC

6

7 Scope Providing Solutions to Healthcare Challenges, economic growth Any Sector Any Discipline NOT blue skies NOT marketing Prevention Detection Diagnosis Management Cure Outcomes Health Eligibility SME’s and Academics Individually Collaboratively NOT large business

8 Business or Academic Led Application? http://www.innovateuk.org/content/competition/biomedical-catalyst.ashx Technology Strategy Board http://www.mrc.ac.uk/Ourresearch/ResearchInitiatives/Translationalresearch/index.htm#P24_1233 Medical Research Council

9 Business Led Applications

10 Status The Technology Strategy Board was set up in 2007 to support UK economic growth To do so, we look at the challenges that offer market opportunities, where the UK has real capability and where the timing is right We work with communities and other organisations to find the right form of support to give companies working in these areas Over 2000 CR&D projects launched 4000 business partnerships and almost all the UK’s universities Together with partners and business, over £2bn invested in UK innovation In 4 years....

11 High Value Manufacturing Digital Services Sustainability Energy Built Environ ment Transport Healthcare Food Supply Development Knowledge Transfer Networks Catapults (High Value Manufacturing) (Cell Therapy) (Offshore Renewable Energy) (Satellite Applications) (Connected Digital Economy) Catapults (High Value Manufacturing) (Cell Therapy) (Offshore Renewable Energy) (Satellite Applications) (Connected Digital Economy) Knowledge Transfer Partnerships Advanced Materials Biosciences Electronics, Photonics and Electrical Systems Information and Communications Technology SMART 2014/15

12 https://connect.innovateuk.org/web/healthktn Knowledge Transfer Networks

13 Photograph by Giulio Mazzarini for the Design Council Source: 2010 report to Ofcom by Plum Consulting (Assisted living technologies for older and disabled people in 2030) £109 billion spent on health care in the UK in 2006/07 £34 billion spent on the over 65s 69% of the total health and care spend in England is associated with Long Term Conditions... Source: Department of Health (2011)

14 Healthcare

15 Future Health Mission 2012 20 UK Health Technology SME’s Boston trade mission Investor, supply chain partner and customer meetings Accelerate your growth potential stateside Opens today! www.futurehealthmission.com

16 http://www.innovateuk.org/content/comp etition/biomedical-catalyst.ashx

17 Feasibility award  evidence gathering to inform decision making  explore and evaluate the commercial potential of an early-stage scientific idea, originating from either academic or industrial research  perform small scale experimental studies, test the market opportunity, identify and develop the route for exploitation Key features: 3 to 12 months Max grant £150k Funded at 75% What it’s not! Feasibility awards will not support development activities such as prototyping and are not aimed at supporting small-scale R&D projects where there is no further research and development planned after the end of the project. Single stage process

18 Early-stage award Proof of concept in model system Key features: 1 to 3 years Max grant per individual £2.4m Min project size is £250k SME’s funded at up to 60% Late-stage award Demonstrate effectiveness in a relevant environment 2 stage process Late –stage award applicants face interview panel

19 Assessments 3 times a year Dates! Max 1 application per category per round Read the guidance

20 On demand briefing information: http://t.co/wjKOluHw

21 Questions?

22 Application Process

23 Expression of Interest (EOI) Stage Full Stage Single Stage Assessment & Panel Single Stage (Feasibility) 2 stage (Early & Late Stage) Assessment & Panel

24 All applications are assessed by independent reviewers drawn from industry and academia Application Assessment What do they look for? Clear and concise answers The right amount of information not too much detail no assumptions Quantification and justification That the applicant has the right people with the right bright idea and the means to exploit its potential

25 The “Ideal Project” A clear commercial opportunity to open up or exploit a significant growth market. A technical challenge that requires the creation of an industrially driven project and innovative and risky research and development to solve. A realistic project with deliverables and applications that are innovative, commercially exploitable and of wider benefit. A demonstrable need for support.

26 Gateway Question: Scope Key Points: “must align” “clear majority of the projects objectives and activities” Don’t write yourself out of scope...! How well does the project fit the competition?

27 Feasibility Studies Application Form

28 Scored out of Question 1 The Idea30 Question 2 The Work Plan20 Question 3 The People15 Question 4 The Deliverable15 Question 5 The Business10 Question 6 Project Costs and Added Value10 BMC Feasibility Studies Questions 1- 6 Plus appendices

29 Finance Summary Table Finance Summary Table (continued) 12345678 Organisation name Organisation registration NumberEnterprise CategoryPostcode Contribution to project by each organisation (£) Funding sought from the Technology Programme (£) Other funding from public sector bodies (£) Total (£) Lead org. 0000 Partner 1 0000 Partner 2 0000 Partner 3 0000 Partner 4 0000 Partner 5 0000 Partner 6 0000 Partner 7 0000 Partner 8 0000 Partner 9 0000 Partner 10 0000 Partner 11 0000 Partner 12 0000 Partner 13 0000 Partner 14 0000 Partner 15 0000 Partner 16 0000 Partner 17 0000 Partner 18 0000 Partner 19 0000 Partner 20 0000 Total (£) 0000 Project Cost Summary (for each project participant) 1. Organisation name 2. Organisation Registration Number 3. Enterprise Category 4. Postcode 5. Contribution to project by each organisation 6.Funding sought from the Technology Strategy Board 7.Other Funding from public sector bodies 8.Total Same for Feasibility and Early & Late Stage EOI

30 Early & Late Stage (two stages) Application Form

31 All questions are equally weighted (10 marks per question) Section 1: The Business Proposition Question 1What is the business opportunity that this project addresses? Question 2What is the size of the market opportunity that this project might open up? Question 3How will the results of the project be exploited and disseminated? Question 4What economic, social and environmental benefits are the project expected to deliver to those inside and outside of the consortium and over what timescale?

32 Section 2: The Project Details Question 5What technical approach will be adopted and how will the project be managed? Question 6What is innovative about the project? Question 7What are the risks (technical, commercial and environmental) to project success? What is the project’s risk management strategy? Question 8Does the project team have the right skills and experience and access to facilities to deliver the intended benefits? All questions are equally weighted (10 marks per question)

33 Section 3: Funding and Added Value Question 9 What is the financial commitment required for the project? Question 10 How does the financial support from the Technology Strategy Board and its funding partners add value? All questions are equally weighted (10 marks per question)

34 Appendices – Early & Late Stage Full Stage applications only These should be used to add justification, graphs, pictures etc to support your application They are not a continuation of the application form Do not use web references Appendix Guidance Appendix A Maximum length: Up to 7 sides of A4 This should be used to provide additional information to address Section 1 of the application form: The Business Proposition. The applicant may wish to include graphics describing the nature of the problem, market dynamics and/or exploitation plans. Appendix B Maximum length: Up to 7 sides of A4 This should be used to provide supporting information to address Section 2 of the application form: The Project Details. For example, a Gantt chart, risk analysis table, project management structure and/or details of evidence for innovation. A Gantt Chart is Mandatory Appendix C Maximum length: ½ side of A4 for each partner and subcontractor This should be used to provide details of the specific expertise and track record of each consortium partner and each subcontractor to address Question 8 of the application form. Academic collaborators may wish to refer to their research standing. Appendix D Maximum length: Up to 8 sides of A4 The Lead Applicant should provide a Business Plan

35 Final Question for Assessors Recommendation RecommendedWould you recommend this project for funding and if not why not?

36 Top Tips Answer the question fully and use all the space available Number your sections & questions Check your application for quality of presentation – make the best impression on the assessors Use capitals when correct to do so but not to draw attention to your case – reviewers do not like it Quantified means put some numbers in Avoid clichés – “Holy Grail” or “Market is massive” Don’t leave your submission until the deadline Please refer to the Guidance for Applicants

37 Funding Criteria: Feasibility Individual or Collaborative... UK business-led Total eligible project costs funded at 75% Consortium members (within overall project funding levels) Industrial (SME)up to 60% Academic100% (of 80% FEC)

38 Funding Criteria: Early & Late Individual or Collaborative... UK business-led Individual entity intervention rather than project SME’s are funded @ up to 60% of their eligible project costs Academics are funded at 100% of 80%FEC HOWEVER; the academic portion may not exceed 50% total eligible project costs (collaborations)

39 Eligible Costs (Industry Partners) Labour Costs Overheads Materials New Capital Equipment Existing Capital Equipment Depreciation Sub-Contracts Travel & Subsistence Other Costs –Other eligible direct costs not included in the above headings Contributions in kind –IP filing costs up to £5,000 (SME only)

40 Ineligible Project Costs (Industry Partners) Input or Output VAT Interest charges, bad debts, profits, advertising, entertainment Hire purchase interest and associated service charges Profit earned by a subsidiary or by an associate undertaking work sub-contracted out under the project Inflation and contingency allowances The value of existing assets such as IPR, data, software and other exploitable assets that are contributed to the project by any collaborator Project Audit Fees

41 What happens if I'm successful?

42 Timelines & Offer Letter Conditional offer letters will be issued approximately 3 weeks after notification. We will require the return of various documents within the timescales stated on the offer letter to validate the grant offer sent Financial project cost review and viability checks undertaken Financial forecast and detailed project plan required The Project may not start until the organisation has received and returned signed acceptance of the Grant Confirmation Letter

43 Preparation Negotiating a Collaboration Agreement can be complex and time consuming. Applicants for Technology Strategy Board funding should therefore start work on this at an early stage in the process, ideally before submitting their full applications The Collaboration Agreement

44 New Projects Workshop Requirement for successful projects. Expectation that each partner has one representative to attend the workshop Outlines process requirements (how to raise a claim etc) Opportunity to meet your Monitoring Officer

45 Grant Claims & Payments All grants are claimable quarterly in arrears Claims can only be made for costs incurred and defrayed (amounts actually paid, may include partial payments) between the project start and end dates All claims will be subject to an independent audit (including all academic partners) In most cases audits are required with the first and last claim Claims are only paid once quarterly reporting and necessary audits are complete All projects are monitored on a quarterly basis including a visit from the appointed Monitoring Officer The monitoring will be carried out against a detailed project plan

46 Key Dates – For Round 2 Timeline SummaryFeasibility StudiesEarly & Late Stage Competition opens28 th June 2012 Final date for RegistrationNoon 24 th October 2012 Submission of First StageNoon 31 st October 2012 Decision provided by Technology Strategy Board End of business 30 th November 18 th November Stage 2 opens (for invited applications)N/A25 th November Feedback to applicantsEnd of business 22 nd December 25 th November Full Stage Briefing Webinar (invited applicants only) N/A26 th November Submission of Full Application – including Je-S submission, finance forms & appendices Noon 9 th January 2013 Interview Stage (Late Stage Awards only)TBA Decision to applicantsEnd February 2013

47 Update round 1 Feasibility = 45 Early Stage = 50 Late Stage = 30 Total grant request approx £100million 1/3 rd projects collaborative

48 Get involved Follow us on twitter @innovate_uk or join the conversation using #BMC Find innovators on _connect https:// https://connect.innovateuk.orghttps://connect.innovateuk.org Visit www.innovateuk.orgwww.innovateuk.org competitions@innovateuk.org Competition Helpline: 0300 321 4357 email: helen.kuhlman@tsb.gov.uk mobile: +44 7748 328234 twitter: @HelenKuhlman


Download ppt "Driving Innovation Biomedical Catalyst Get involved Follow us on or join the conversation using #BMC Find innovators on _connect https://"

Similar presentations


Ads by Google